CHEWY INC. DL-,01 Logo
US16679L1098
A2PL6S
CHWY

CHEWY INC. DL-,01

Chargement des cours...

Prévisions

L'objectif de cours moyen des analystes est de 26,17 € (+28,10 %). La médiane est de 25,40 € (+24,33 %).

Acheter
  29
Conserver
  10
Vendre
  0

Discussions dans la communauté

Il n'y a pas encore de discussion sur cet actif.

Lancer une discussion

  • Chewy shifts growth focus to pet health, AI and clinics

    Chewy is prioritizing U.S. pet health services—pharmacy, supplements, prescription diets, insurance, telemedicine and veterinary clinics—as its next growth engine while leveraging Autoship, mobile engagement and AI. About one-quarter of customers buy from Chewy Pharmacy, and pharmacy customers add roughly $300–$500 in annual spending; the company operates 60 clinics that are outperforming expectations. Chewy targets 150,000–250,000 net active-customer additions and aims for long-term high-single-digit to low-double-digit revenue growth, planning to self-fund investments and seek about $50 million in AI savings in 2027. Acquisition focus will be health-first, with international expansion a lower priority. » Plus sur finance.yahoo.com


  • Chewy bets on health, AI and clinics as growth drivers

    At the Goldman Sachs conference, Chewy announced plans to evolve from a pure pet-supplies retailer into a comprehensive pet-health platform, increasing investment in AI, veterinary clinics and pharmacies. Gross margin has risen from 18% at IPO to around 30%, driven by Autoship, the health business and supply-chain optimizations. Chewy now operates about 60 clinics, plans expansion through acquisitions such as Modern Animal, and intends to use AI tools (Chewy AI) and agentic commerce to boost customer retention and efficiency. Management expects to fund many growth investments from the core business, aims for further margin improvement and is also considering opportunistic M&A in the health sector. » Plus sur de.investing.com


  • Chewy faces slowdown and margin questions after mixed Q2 beat and 48% slide

    Chewy reported Q2 sales up 7.3% to $3.33 billion, adjusted EPS $0.36 and raised its full-year outlook, but organic revenue growth slowed to 5.7% and adjusted EBITDA outperformance relied on one-time items. Analysts cut ratings and price targets, with Evercore ISI downgrading to In Line amid concerns about a lack of clear growth catalysts and competitive pressure from Amazon and Walmart. The stock has fallen about 48% from its 52-week high and trades near multi-year lows; the report says the shares are only attractive if deceleration proves cyclical and future quarters show organic reacceleration and sustainable margin expansion. » Plus sur finance.yahoo.com


  • JPMorgan downgrades Chewy and cuts price target to $24

    JPMorgan downgraded Chewy from “Overweight” to “Neutral” and cut its price target from $29 to $24, after which the stock fell about 3.3%. Analyst Doug Anmuth cited persistent macroeconomic headwinds weighing on organic growth and sales of non‑essential products. Chewy gained market share despite the environment, reported a net increase of 208,000 active customers, raised its full‑year revenue outlook in the middle of the range by roughly $40 million, but does not see a meaningful recovery in consumer behavior in 2026; the improved EBITDA margin for the quarter was largely due to one‑off gross margin benefits of about $15 million. » Plus sur de.investing.com


  • JPMorgan downgrades Chewy to neutral over tepid organic demand

    JPMorgan has downgraded Chewy from "Overweight" to "Neutral", citing persistent macroeconomic pressure on organic growth as the main reason. Analyst Doug Anmuth sets a $24 price target for December 2027, based on roughly seven times the estimated adjusted EBITDA of $1.2 billion for 2028. Chewy fell about 9% after quarterly results but continues to gain market share and reports robust customer metrics; the quarter's margin strength was largely driven by one-off effects. JPMorgan praises acquisitions (SmartPak, Modern Animal), AI initiatives and share buybacks, but views the growth outlook as more subdued. » Plus sur de.investing.com

Données financières de l'entreprise

Au dernier trimestre, CHEWY INC. DL-,01 a réalisé un chiffre d'affaires de 2,88 Md € et un bénéfice net de 69,74 M €
(EUR) août 2026
YoY
Chiffre d'affaires 2,88 Md 7,68 %
Bénéfice brut 875,99 M 7,72 %
Bénéfice net 69,74 M 30,32 %
EBITDA 138,52 M 49,29 %

Données fondamentales

Indicateur Valeur
Capitalisation boursière
8,21 Md €
Nombre d'actions
401,93 M
Plus haut/bas sur 52 semaines
33,87 € - 15,78 €
Dividendes Non
Bêta
1,33
Ratio P/E
34,12
Ratio PEG
0,44
Ratio P/B
24,70
Ratio P/S
0,69

Profil de l'entreprise

Chewy, Inc., ainsi que ses filiales, exerce une activité de pure player du commerce électronique aux États-Unis. La société propose des aliments et friandises pour animaux, des fournitures pour animaux et des médicaments vétérinaires, ainsi que d'autres produits de santé animale, de même que des services pour animaux destinés aux chiens, chats, poissons, oiseaux, petits animaux, chevaux et reptiles, par l'intermédiaire de son site de vente au détail www.chewy.com ainsi que de ses applications mobiles. Elle propose environ 100 000 produits issus de 3 000 marques partenaires. La société a été fondée en 2010 et son siège social se situe à Dania Beach, en Floride.

Nom
CHEWY INC. DL-,01
PDG
Sumit Singh
Siège social Plantation, fl
États-Unis
Site web
Secteur
Consommation discrétionnaire
Industrie
Distribution spécialisée
Introduction en bourse
14/06/2019
Employés 18 000

Symboles boursiers

Bourse Symbole
NYSE
CHWY
Frankfurt
3HH.F
Düsseldorf
3HH.DU
München
3HH.MU
SIX
CHWY.SW
🍪

Parqet  utilise des cookies. En savoir plus